Recurrent Childhood Acute Lymphoblastic Leukemia Terminated Phase 1 Trials for DB00773 (Etoposide)

IndicationStatusPhase
DBCOND0028597 (Recurrent Childhood Acute Lymphoblastic Leukemia)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00101205Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or LymphomaTreatment